Facebook Twitter LinkedIn
Board of Directors
Board of Directors
Policy Fellows
Institutes & Affiliates
1130 K Street, Suite 280, Sacramento, CA, 95814-3965, (916) 492-0996
Support CCST


Charles F. Kennel (Board Chair)
Scripps Institution of Oceanography
UC San Diego
Bruce Alberts
UC San Francisco
Jeffrey Armstrong
California Polytechnic State University SLO
Ann Arvin
Stanford University
Albert Carnesale
Bruce B. Darling
National Academy of Sciences
National Research Council
Dori Ellis
Sandia California
Richard C. Flagan
Charles E. Harper
Jariet Technologies
Amber Mace (Interim Executive Director)
Alexandra Navrotsky
UC Davis
Lisa Rossbacher
Humboldt State University
Judith Swain (Council Vice Chair)
Physiowave, LLC
James Sweeney
Stanford University
Van Ton-Quinlivan
California Community Colleges
Samuel Traina
UC Merced
Eugene Tu
NASA Liaison
Corey Goodman

CCST Board Member
Corey Goodman

Managing Partner, venBio Partners LLC

Corey Goodman is a scientist, educator, and entrepreneur. Corey has been a member of CCST since 2007, and was appointed Council Chair in 2014.

With a B.S. from Stanford University and Ph.D. from U.C. Berkeley, he spent 25 years as Professor of Biology at Stanford University and Evan Rauch Chair of Neurobiology at Berkeley (Dept. of Molecular and Cell Biology), where he was Howard Hughes Medical Institute Investigator, Head of the Neurobiology Division, and co-founder and Director of the Wills Neuroscience Institute. He published over 200 peer-reviewed papers. He is currently an Adjunct Professor of Anatomy and Biochemistry & Biophysics at U.C. San Francisco.

Dr. Goodman is an elected member of the National Academy of Sciences, American Academy of Arts and Sciences, and American Philosophical Society, and recipient of many honors including the Alan T. Waterman Award, Canada Gairdner Biomedical Award, March-of-Dimes Prize in Developmental Biology, Reeve-Irvine Research Medal, and Dawson Prize in Genetics from Trinity College Dublin.

Dr. Goodman moved into biotechnology to help apply biomedical discoveries to human health. He has co-founded six biotechnology companies, and led one of them as President and CEO from a private to public company until its acquisition. He was recruited as President and founder of Pfizer's Biotherapeutics and Bioinnovation Center and a member of Pfizer's executive leadership team.

Today Dr. Goodman is a Managing Partner of venBio Partners LLC, a strategic capital firm investing in innovative therapeutics for major unmet medical needs, based on a model of strategic investment with Amgen, Baxter, and PPD.

Dr. Goodman is currently Chair of the Board of Second Genome, Oligasis, Ossianix, Labrys Biologics, Solstice Biologics, and Heart Metabolics. He is a member of the Board of Mirna.

Amongst his other public policy roles, Dr. Goodman is a member of the board of the Pacific Institute, former Chair of the National Research Council's Board on Life Sciences, and past President of the McKnight Endowment Fund for Neuroscience. He is an advisor to numerous biomedical foundations.

Updated 3/7/14